. Drug repurposing for venetoclax-resistant acute myeloid leukemia.
LADUNGOVÁ, Adriana, Daniel BUŠA, Yusuf LODHI, Jan HÝL, Martin ČULEN and Michal ŠMÍDA. . Drug repurposing for venetoclax-resistant acute myeloid leukemia. In PhD retreat 2022, Telč. 2022. |
Other formats:
BibTeX
LaTeX
RIS
|
Basic information | |
---|---|
Original name | . Drug repurposing for venetoclax-resistant acute myeloid leukemia. |
Authors | LADUNGOVÁ, Adriana, Daniel BUŠA, Yusuf LODHI, Jan HÝL, Martin ČULEN and Michal ŠMÍDA. |
Edition | PhD retreat 2022, Telč, 2022. |
Other information | |
---|---|
Type of outcome | Conference abstract |
Confidentiality degree | is not subject to a state or trade secret |
Organization unit | Central European Institute of Technology |
Tags | NÚVR_CEITEC |
Changed by | Changed by: Bc. Kateřina Kolesová, učo 112275. Changed: 20/1/2023 15:09. |
Links | |
---|---|
LX22NPO5102, research and development project | Name: Národní ústav pro výzkum rakoviny (Acronym: NÚVR) |
Investor: Ministry of Education, Youth and Sports of the CR, National institute for cancer research, 5.1 EXCELES | |
MUNI/A/1330/2021, interní kód MU | Name: Nové přístupy ve výzkumu, diagnostice a terapii hematologických malignit IX (Acronym: VýDiTeHeMa IX) |
Investor: Masaryk University | |
MUNI/A/1419/2021, interní kód MU | Name: Specifický výzkum v oblasti „Life Sciences“ |
Investor: Masaryk University |
PrintDisplayed: 13/10/2024 22:23